Product Images Pregabalin

This is a clinical trial result where the efficacy of Pregabalin to relieve pain was evaluated at different dosages. The percentage of patients improved was 100. The graph indicates that Pregabalin dosages of 200mg and 100mg three times a day, and 25mg three times a day showed improvement in pain from baseline compared to patients taking placebo. However, the specific percentage of improvement is not clear.*

This appears to be a graph that compares the percent improvement in pain from baseline for three groups: one group is taking Pregabalin 100mg three times a day, the second group is taking Pregabalin 50mg three times a day, and the third group is taking a placebo. The graph shows different levels of improvement in pain based on the percentage of patients who reported improvement, grouped into ranges such as 0-20%, 20-30%, 30-40%, and so on up to 80-100%.*

This text shows statistical significance measured by p-values in a study. The p-values shown are less than 0.0001, which indicates a highly significant result. The study seems to have looked at some sort of dose-response relationship, with different doses of a treatment (possibly placebo) administered. However, further details are not available.*

This is a chart showing the percentage of patients improved on different doses of Pragabalin and Placebo in terms of pain relief. The chart indicates a hundred percent improvement for Pragabalin 600mg and 450mg daily dose and lower percentages in pain relief for lower doses. The improvement percentage is not available for Placebo as it is not mentioned in the chart.*

This text represents a formula used in some medical calculations. The formula involves subtracting the product of age and weight from 1140. The resulting value is then multiplied by a factor of T2 s e gL (with an additional factor of 0.85 for female patients). Without additional information about the specific context in which this formula is used, it is difficult to provide more context or meaning.*